Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in ...

Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...

The Joint Clinical Research Centre (JCRC) at Lubowa in partnership with Asea BioTherapeutics (ABT) today successful treated their first client with cutting-edge stem cell therapy, marking a historic ...

Utrophin increase in muscle cells after transcriptional adaptation normalises cell function in Duchenne muscular ...

At Week 14, 69% (71% of b/tsDMARD-naïve and 66% of b/tsDMARD-experienced) or 220 of the 318 rosnilimab-treated patients across all doses achieved CDAI LDA and were eligible to remain on continued ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

IIT Madras has developed a patented drug delivery system targeting breast cancer cells with nanomaterials, reducing side ...

Researchers at the Indian Institute of Technology (IIT), Madras have developed and patented a nextgGeneration drug delivery system to treat breast cancer, which is one of the leading causes of ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...